Category: Webinar

Introducing SPEAR epTau 217 and eMTBR-Tau: Dissecting Alzheimer’s pathologies from early Tau phosphorylation to Tau tangles

Sep 9, 2026, 11:00 am ET Virtual The development of reliable blood-based biomarkers is transforming Alzheimer’s disease (AD) research, offering new opportunities to detect pathological changes earlier and monitor disease progression with greater precision.  In this SelectScience® webinar, held in partnership with Spear Bio, experts will introduce two novel blood-based biomarker assays designed to advance AD […]

Read More

Enhance Neurodegenerative Detection and Monitoring with BD-pTau 217 and α-Syn

Tuesday, May 12, 2026 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central) The ability to reliably detect blood-based biomarkers such as brain-derived pTau 217 (BD-pTau 217) and α-synuclein species across healthy and disease populations has remained a significant challenge in neurodegenerative disease research. Recent advances in ultra-sensitive immunoassay technology are now […]

Read More

Enhanced early Alzheimer’s detection with the novel SPEAR UltraDetect pTau 217 Assay

Friday, January 30 at 10:00 EST | 07:00 PST | 15:00 GMT | 16:00 CET This SelectScience webinar will highlight how the SPEAR UltraDetect™ platform enables ultra-sensitive and highly specific detection of plasma pTau 217 for enhanced accuracy of early Alzheimer’s detection.  Attendees will gain an overview of how SPEAR UltraDetect pTau 217 performance compares […]

Read More